martedì, 27 luglio 2021
1 Marzo 2018

ASCO Clinical Practice Guideline: Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy

February 27, 2018 – As reported in the Journal of Clinical Oncology by Julie R. Brahmer, MD, of the Johns Hopkins Kimmel Cancer Center, and colleagues, ASCO has released a clinical practice guideline on management of immune-related adverse events in patients receiving immune checkpoint inhibitor therapy. To develop the guideline, ASCO brought together a multidisciplinary, multiorganizational panel of experts in medical oncology, dermatology, gastroenterology … (leggi tutto)